The agency says pairing drug sponsors with research institutions could cut development timelines by 6 to 12 months ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Brain organoids allow researchers to personalize testing medications Psychiatric drug ...

Purdue researchers developed a mass spectrometry platform that accelerates cancer drug discovery by integrating synthesis, ...

The FDA’s new draft guidance on Bayesian methods in clinical trials has been hailed by some as a breakthrough that could speed drug development. But statisticians and researchers are divided on ...

For the millions of people using glucagon-like peptide-1 receptor agonists (GLP-1), a dose has long meant a weekly appointment with a needle. With the U.S. Food and Drug Administration (FDA) approving ...

A new medication could double survival time in patients with advanced pancreatic cancer, according to Phase III clinical ...

Samsung and Alcedis will explore how Galaxy Watch biometric data can support clinical trials, digital endpoints, and drug ...

Pancreatic cancer is one of the deadliest cancers and the third-leading cause of cancer-related death in the United States.

The drug daraxonrasib nearly doubled the overall survival rates of pancreatic cancer patients. Here's how it works and who ...